ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,186, issued on Dec. 9, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Bicyclic heterocyclic compounds useful as IRAK4 inhibitors" was invented by Saleem Ahmad (Wall, N.J.), Kandhasamy Sarkunam (Hosur, India), Ling Li (Pennington, N.J.), Lidet A. Negash (Plainsboro, N.J.) and John Hynes (Washington Crossing, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein: X is CR4a or N; Y is CR4b or N; Z is CR4d or N; provided that zero or 1 of X, Y, and Z is N; and R1, R2, R3, R4a, R4b, R4c, and R4d are define herein. Also disclosed are methods of using such compounds as m...